Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease

Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease

Backgrounds: Optimal concentration of ustekinumab (UST) predicting endoscopic remission has not been fully investigated in Crohn’s disease (CD). We aimed to identify the optimal UST trough levels predicting clinical, laboratory and endoscopic remission in CD patients. Methods: Twenty-eight patients...

Full description

Bibliographic Details
Main Authors: Andoh, A. (Author), Bamba, S. (Author), Hirayama, H. (Author), Imai, T. (Author), Inatomi, O. (Author), Morita, Y. (Author), Takahashi, K. (Author), Yoshida, A. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Enteroscopy
Therapeutic drug monitoring
Ustekinumab
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items